- Home
- ETNB vs ELME Comparison
ETNB vs ELME Comparison
Compare ETNB & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- ELME
- Stock Information
- Founded
- ETNB 2018
- ELME 1960
- Country
- ETNB United States
- ELME United States
- Employees
- ETNB N/A
- ELME N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- ELME Real Estate Investment Trusts
- Sector
- ETNB Health Care
- ELME Real Estate
- Exchange
- ETNB Nasdaq
- ELME Nasdaq
- Market Cap
- ETNB 1.5B
- ELME 1.4B
- IPO Year
- ETNB 2019
- ELME N/A
- Fundamental
- Price
- ETNB $8.87
- ELME $17.22
- Analyst Decision
- ETNB Strong Buy
- ELME Hold
- Analyst Count
- ETNB 10
- ELME 6
- Target Price
- ETNB $27.22
- ELME $18.20
- AVG Volume (30 Days)
- ETNB 1.5M
- ELME 1.0M
- Earning Date
- ETNB 11-06-2025
- ELME 11-03-2025
- Dividend Yield
- ETNB N/A
- ELME 4.18%
- EPS Growth
- ETNB N/A
- ELME N/A
- EPS
- ETNB N/A
- ELME N/A
- Revenue
- ETNB N/A
- ELME $245,911,000.00
- Revenue This Year
- ETNB N/A
- ELME N/A
- Revenue Next Year
- ETNB N/A
- ELME $6.20
- P/E Ratio
- ETNB N/A
- ELME N/A
- Revenue Growth
- ETNB N/A
- ELME 4.59
- 52 Week Low
- ETNB $4.16
- ELME $13.95
- 52 Week High
- ETNB $11.84
- ELME $18.49
- Technical
- Relative Strength Index (RSI)
- ETNB 43.45
- ELME 66.25
- Support Level
- ETNB $8.46
- ELME $16.86
- Resistance Level
- ETNB $9.47
- ELME $17.24
- Average True Range (ATR)
- ETNB 0.46
- ELME 0.18
- MACD
- ETNB -0.02
- ELME 0.01
- Stochastic Oscillator
- ETNB 33.33
- ELME 93.33
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.